Person: TURNA, SEVAL
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Organizational Unit
Job Title
Last Name
TURNA
First Name
SEVAL
Name
12 results
Search Results
Now showing 1 - 10 of 12
- PublicationOpen AccessBRAF V600E mutation and BRAF VE1 immunoexpression profiles in different types of glioblastoma.(2018-08-01) TURNA, S; GEÇER, MELİN; Hatiboğlu, MUSTAFA AZİZ; ABDALLAH, ANAS ABDELRAHIM SA; TOSUNER, ZEYNEP; GEÇER, MELİN; HATİBOĞLU, MUSTAFA AZİZ; ABDALLAH, ANAS ABDELRAHıM SA; TURNA, SEVAL
- PublicationOpen AccessImmunocytoexpression profile of ProExC in smears interpreted as ASC-US, ASC-H, and cervical intraepithelial lesion(2017-01-01T00:00:00Z) Tosuner, Zeynep; Turkmen, Ilknur; Arici, Sema; Sonmez, Cavide; Turna, Seval; Onaran, Oyku; TOSUNER, ZEYNEP; TURNA, SEVALAims: We aimed to investigate the immunocytoexpression profiles of a novel assay ProEx C for topoisomerase II alpha (TOP2A) and minichromosome maintenance protein 2 (MCM2) in abnormal interpreted smears. Settings and Design: Screening programs with Papanicolaou smear and high risk group human papilloma virus testing have yielded a dramatic reduction of cervical cancer incidence. However, both of these tests have limited specificity for the detection of clinically significant cervical high grade lesions. ProEx C for topoisomerase II alpha (TOP2A) and minichromosome maintenance protein 2 (MCM2) has been considered to have tight association with high grade intraepithelial lesions. Materials and Methods: A total number of 54 SurePath cervical cytology specimens of patients previously interpreted as atypical squamous cells-undetermined significance (ASC-US), atypical squamous cells-cannot exclude high grade squamous intraepithelial lesion (ASC-H), low grade squamous intraepithelial lesion (LSIL), and high grade squamous intraepithelial lesion (HSIL) were included in our study. Results and Conclusions: ProEx C was positive in 14 of HSILs (100%), 3 of 19 LSILs (16%), 2 of 4 ASC-Hs, and none of ASC-USs (0%). The ProEx C test showed very intense nuclear staining in all cytologically abnormal cells. Further studies are indicated to evaluate the diagnostic role of ProEx C.
- PublicationMetadata onlyExpression Analysis of Mir-16-5p Mirna in Polymorphic Helicobacter Pylori Genotypes in Gastric Cancer(2019-12-05T00:00:00Z) ŞENER, ŞAFAK; TURNA, SEVAL; IRMAK YAZICIOĞLU, MELİHA BURCU; TURNA, SEVAL
- PublicationMetadata onlyComparison of HER-2 Amplification with Clinicopathological and Prognostic Parameters in Metastatic Gastric Carcinomas(2020-08-01T00:00:00Z) GEÇER, MELİN; TURNA, SEVAL; GEÇER, MELİN; TURNA, SEVAL; GÜCİN, ZÜHAL
- PublicationMetadata onlyMETASTATIK MIDE TÜMÖRLERINDE CERB-B2 SONUÇLARININ CD133 VE CD44 KANSER KÖK HÜCRE BELIRTECI EKSPRESYON DURUMU VE KLINIKOPATOLOJIK PARAMETRELERLE KARŞILAŞTIRILMASI(2019-10-23T00:00:00Z) GEÇER, MELİN; BÜYÜKPINARBAŞILI, NUR; TURNA, SEVAL; BEŞİROĞLU, MEHMET; GEÇER, MELİN; TURNA, SEVAL; GÜCİN, ZÜHAL
- PublicationMetadata onlyThe association of GLUT-1, Galectin 3 and Claudin 1 staining with the type of renal tumors(2019-01-01T00:00:00Z) ÇOBAN, GANİME; TURNA, SEVAL; YILDIZ, PELİN; ÜNVER, NURCAN; BÜYÜKPINARBAŞILI, NUR; ERSÖZ, CEVPER; GÜCİN, ZÜHAL; TURNA, SEVAL; YILDIZ, PELİN; ERSÖZ, CEVPER; GÜCİN, ZÜHAL
- PublicationMetadata onlyMEDICINE&HEALTH(2021-01-01T00:00:00Z) TURNA, SEVAL; TURNA, SEVAL
- PublicationMetadata onlyKanserde Hedefe Yönelik Monoklonal Antikor Tedavisi(2018-09-01T00:00:00Z) IRMAK YAZICIOĞLU, MELİHA BURCU; CEYLANER, BETÜL; TURNA, SEVAL; KAŞIKÇI, HAVVA; TURNA, SEVAL
- PublicationMetadata onlySurvivin and Ki-67 expression in leiomyomas,leiomyoma variants, leiomyosarcoma, and STUMP : Animmunohistochemical and clinical follow-up study(2019-12-01T00:00:00Z) GÖKMEN KARASU, AYŞE FİLİZ; SÖNMEZ, FATMA CAVİDE; TURAN, HASAN; COMBA, CİHAN; TURNA, SEVAL; ILVAN, SENNUR; ARICI, DİLEK SEMA; GÖKMEN KARASU, AYŞE FİLİZ; TURNA, SEVAL
- PublicationMetadata onlyEffect of mesenchymal stem cells on BAX and BCL 2 genes in lung cancer cells(2021-12-07T00:00:00Z) Turna, Seval; TURNA, SEVAL